JP2014519483A5 - - Google Patents

Download PDF

Info

Publication number
JP2014519483A5
JP2014519483A5 JP2014505603A JP2014505603A JP2014519483A5 JP 2014519483 A5 JP2014519483 A5 JP 2014519483A5 JP 2014505603 A JP2014505603 A JP 2014505603A JP 2014505603 A JP2014505603 A JP 2014505603A JP 2014519483 A5 JP2014519483 A5 JP 2014519483A5
Authority
JP
Japan
Prior art keywords
nutritional composition
protein
composition according
vitamin
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014505603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014519483A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/057092 external-priority patent/WO2012143402A1/en
Publication of JP2014519483A publication Critical patent/JP2014519483A/ja
Publication of JP2014519483A5 publication Critical patent/JP2014519483A5/ja
Pending legal-status Critical Current

Links

JP2014505603A 2011-04-18 2012-04-18 α−ヒドロキシイソカプロン酸を含有する栄養組成物 Pending JP2014519483A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161476345P 2011-04-18 2011-04-18
US61/476,345 2011-04-18
PCT/EP2012/057092 WO2012143402A1 (en) 2011-04-18 2012-04-18 Nutritional compositions comprising alpha-hydroxyisocaproic acid

Publications (2)

Publication Number Publication Date
JP2014519483A JP2014519483A (ja) 2014-08-14
JP2014519483A5 true JP2014519483A5 (enExample) 2016-09-15

Family

ID=45976400

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014505603A Pending JP2014519483A (ja) 2011-04-18 2012-04-18 α−ヒドロキシイソカプロン酸を含有する栄養組成物
JP2014505604A Pending JP2014512371A (ja) 2011-04-18 2012-04-18 α−HICA及びシトルリンを含有する栄養組成物
JP2014505606A Pending JP2014511890A (ja) 2011-04-18 2012-04-18 α−HICA及びα−ケトグルタル酸を含有する栄養組成物
JP2014505605A Pending JP2014512372A (ja) 2011-04-18 2012-04-18 α−HICA及びエイコサペンタエン酸を含有する栄養組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2014505604A Pending JP2014512371A (ja) 2011-04-18 2012-04-18 α−HICA及びシトルリンを含有する栄養組成物
JP2014505606A Pending JP2014511890A (ja) 2011-04-18 2012-04-18 α−HICA及びα−ケトグルタル酸を含有する栄養組成物
JP2014505605A Pending JP2014512372A (ja) 2011-04-18 2012-04-18 α−HICA及びエイコサペンタエン酸を含有する栄養組成物

Country Status (13)

Country Link
US (4) US20140044685A1 (enExample)
EP (4) EP2699111A1 (enExample)
JP (4) JP2014519483A (enExample)
CN (4) CN103458710A (enExample)
AU (4) AU2012244750A1 (enExample)
BR (2) BR112013026706A2 (enExample)
CA (4) CA2831001A1 (enExample)
MX (4) MX2013012228A (enExample)
PH (4) PH12013501926A1 (enExample)
RU (4) RU2013151083A (enExample)
SG (4) SG193938A1 (enExample)
WO (4) WO2012143404A1 (enExample)
ZA (4) ZA201308607B (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2583563A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Whey protein micelles against muscle atrophy and sarcopenia
PL2583566T3 (pl) * 2011-10-21 2016-01-29 Nestec Sa Micele serwatkowego białka do zwiększania masy mięśni i sprawności
ITBO20120226A1 (it) * 2012-04-24 2013-10-25 Alfa Wassermann Spa Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso.
CN103783532B (zh) * 2012-10-29 2016-06-08 杭州纽曲星生物科技有限公司 一种抗老年性肌肉衰减的复合蛋白质粉及其制备方法
US20160051814A1 (en) * 2013-04-15 2016-02-25 Nestec S.A. Use of whey protein in combination with electrical muscle stimulation
BR112015030767B1 (pt) * 2013-06-10 2021-03-30 N.V. Nutricia Uso de uma composição
WO2015048334A2 (en) 2013-09-25 2015-04-02 Pronutria, Inc. Edible species nutritive polypeptides and methods of production and use thereof
CA2923705C (en) 2013-10-09 2024-05-14 Nestec S.A. Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
CN103637212B (zh) * 2013-12-13 2014-12-24 广东省农业科学院蚕业与农产品加工研究所 一种具有降血脂作用的管饲临床营养品及其制备方法
EP3115047B1 (en) * 2014-03-07 2020-05-06 Ajinomoto Co., Inc. Debility preventative
JPWO2015137387A1 (ja) * 2014-03-11 2017-04-06 協和発酵バイオ株式会社 筋肉増強剤
WO2015148384A1 (en) * 2014-03-26 2015-10-01 Abbott Laboratories Nutritional supplement powder
US20190054093A1 (en) * 2014-04-04 2019-02-21 Nektium Pharma Sl Treatment of sarcopenia with ecdysteroids
WO2015160262A1 (en) * 2014-04-16 2015-10-22 Amerikal Nutraceutical Corp Anti-aging composition
JP2017518078A (ja) * 2014-06-03 2017-07-06 アボット・ラボラトリーズAbbott Laboratories ジャガイモを基にしたタンパク質混合物およびジャガイモタンパク質を含む栄養組成物
US11102994B2 (en) 2014-08-21 2021-08-31 Clearfast Inc. Pre-operative carbohydrate-rich beverage composition and methods of treatment
WO2016044167A1 (en) * 2014-09-15 2016-03-24 Abbott Laboratories Methods for increasing muscle strength and mobility in subjects experiencing significant physical inactivity using gamma linolenic acid
ES2960218T3 (es) * 2014-10-14 2024-03-01 Nestle Sa Mejora en la funcionalidad del músculo de hombres ancianos
US11040022B2 (en) * 2015-02-05 2021-06-22 William H. Cross, III Compositions and methods for pain relief
NL2015032B1 (en) * 2015-06-26 2017-01-24 Vitalnext B V Compositions and methods for the treatment of malnutrition.
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CN108473384A (zh) 2015-10-27 2018-08-31 细胞酶动物营养品公司 动物营养成分及相关方法
RU2614881C1 (ru) * 2015-12-29 2017-03-30 Общество с ограниченной ответственностью "Мобильный доктор" Комплекс биологически активных веществ, защищающих спортсменов от перетренированности
EP3397960B1 (en) * 2015-12-30 2020-01-29 Société des Produits Nestlé S.A. Method for determining fat free body mass
US10912323B2 (en) 2016-02-29 2021-02-09 Abbott Laboratories Nutritional supplement powder
US11612632B2 (en) 2017-04-25 2023-03-28 William H. Cross, III Compositions and methods for treatment of prediabetes
CA3021169A1 (en) * 2016-05-20 2017-11-23 Nestec S.A. Mct-based nutrition blend for cardiac protection and treating degenerative mitral valve disease in companion animals
CN106213522A (zh) * 2016-08-05 2016-12-14 郑家福 营养保健品
RU2635373C1 (ru) * 2016-08-25 2017-11-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Биологически активная добавка для повышения общей работоспособности
HUE046449T2 (hu) 2016-09-13 2020-03-30 Allergan Inc Stabilizált, nem fehérje eredetû, clostridiális toxin készítmények
EP3711493A1 (en) * 2016-11-16 2020-09-23 Fresenius Kabi Deutschland GmbH Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
KR20180081361A (ko) * 2017-01-06 2018-07-16 연세대학교 산학협력단 인돌-3-카비놀 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용 조성물
WO2020106746A1 (en) * 2018-11-19 2020-05-28 Heh Research & Development Services, Inc. Biologic enhancement formulation
US12213952B1 (en) 2017-03-09 2025-02-04 Heh Research & Development Services, Inc. Biologic enhancement formulation
IL270162B2 (en) * 2017-04-25 2025-07-01 Buck Inst Res Aging ?-ketoglutarate (akg) and (i) a vitamin a compound, or (ii) a vitamin d compound, for use in delaying onset or delaying progression of frailty
US11260088B2 (en) 2017-06-21 2022-03-01 Abbott Laboratories Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
CN107242572A (zh) * 2017-07-06 2017-10-13 广州彤博士健康科技有限公司 营养补充剂及制备方法
MA49906A (fr) 2017-08-14 2020-06-24 Axcella Health Inc Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
CN107616505B (zh) * 2017-10-24 2020-12-25 精晶药业股份有限公司 一种含有鸟氨酸酮戊二酸的保健品及其制备方法
PL238310B1 (pl) * 2017-10-31 2021-08-09 Top Energy Set Spolka Z Ograniczona Odpowiedzialnoscia Preparat leczniczy oraz sposób jego uzyskiwania
US11304971B2 (en) 2018-01-31 2022-04-19 William H. Cross, III Metformin compositions and methods for treatment of diabetes
US11351188B2 (en) 2018-01-31 2022-06-07 William H. Cross, III Folic compositions and methods for treatment of diabetic neuropathies
US11154523B2 (en) 2018-01-31 2021-10-26 William H. Cross, III Compositions and methods for treatment of diabetic neuropathies
US12329818B2 (en) 2018-02-22 2025-06-17 William H. Cross, III Topical compositions and methods for treatment of diabetic neuropathies
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
IL281761B2 (en) 2018-09-25 2025-09-01 Ponce De Leon Health Designated Activity Company Process for preparing calcium alpha-ketoglutarate
KR102171518B1 (ko) * 2019-02-21 2020-10-29 한양대학교 에리카산학협력단 지골피 추출물을 유효성분으로 함유하는 근 위축 예방 또는 치료용 조성물
EP3934441A1 (en) * 2019-05-31 2022-01-12 Société des Produits Nestlé S.A. Mct-based nutrition blend for providing health benefits in animals
EP3980000A4 (en) * 2019-06-10 2023-06-21 Buck Institute for Research on Aging METHODS AND COMPOSITIONS FOR ALTERING THE SENSCENCE OF ASSOCIATED SECRETORY PHENOTYPES
CN110226756A (zh) * 2019-06-18 2019-09-13 山东理工大学 预防和缓解2型糖尿病患者肌少症的蛋白组件及制备方法
TWI774966B (zh) * 2019-06-25 2022-08-21 生合生物科技股份有限公司 胚芽乳桿菌bcrc 910734用於提升老年個體的肌力以及治療肌肉減少症的用途
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
WO2021133962A1 (en) * 2019-12-27 2021-07-01 Grove Collaborative, Inc. Confections for skin protection: compositions, methods for making, and applications thereof
CA3173150A1 (en) * 2020-03-30 2022-10-07 Compagnie Gervais Danone Fermented milk compositions for use in methods of nutritional supplementation
JP7742026B2 (ja) * 2020-04-03 2025-09-19 三菱瓦斯化学株式会社 筋肉増強剤
CA3188646A1 (en) * 2020-07-02 2022-01-06 Ponce De Leon Health Designated Activity Company Compositions and methods for treating crp-mediated diseases
CA3189890C (en) * 2020-08-18 2025-05-13 Foodscience Corp ANTIOXIDANT COMPOUND ENCAPSULATED IN A POLYMERIZED WHEY PROTEIN AND ITS PREPARATION PROCESS
FI129515B (en) * 2020-11-06 2022-03-31 Salarusta Oy FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY
CN112899204B (zh) * 2021-03-19 2022-06-28 杭州百芮生物科技有限公司 一种益生菌冻干外壳复合保护剂及其应用
CN113398144B (zh) * 2021-07-27 2022-04-01 陈玉松 核苷酸混合物在制备预防或缓解老年肌少症制剂中的应用
CN114029085B (zh) * 2021-12-06 2024-02-27 中触媒新材料股份有限公司 一种烯烃环氧化催化剂及其制备方法和应用
WO2023121696A1 (en) * 2021-12-20 2023-06-29 Schneider Todd C Formulation and treatment for extended micronutrient therapy
WO2025151881A1 (en) * 2024-01-12 2025-07-17 Heh Research & Development Services, Inc. Biologic enhancement formulation
CN119564838A (zh) * 2025-02-06 2025-03-07 杭州纽龙日尚生物制品有限公司 一种基于2-氧代戊二酸的组合物及制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
GB1442154A (en) * 1973-04-30 1976-07-07 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body
GB1444621A (en) * 1973-04-30 1976-08-04 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogues of amino acids
GB1511302A (en) * 1974-04-15 1978-05-17 Univ Johns Hopkins Pharmaceutical compositions comprising amino acid analogues
US4752619A (en) 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
SE8803144L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Energisubstrat
US5646187A (en) * 1992-05-20 1997-07-08 Ab Erik Vinnars Use of alpha-ketoglutarate
SE9201584D0 (sv) * 1992-05-20 1992-05-20 Vinnars Erik Ab Use of alpha-ketoglutarate
SE0201713D0 (sv) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US8795693B2 (en) * 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20050256192A1 (en) * 2004-04-30 2005-11-17 Gardiner Paul T Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual
FI20045395A7 (fi) * 2004-10-21 2006-04-22 Oy Elmomed Ltd Ravintoainelisä ja sen käyttö
CN101179943B (zh) * 2005-05-23 2013-06-26 卡夫食品环球品牌有限责任公司 填充液体的咀嚼型胶基糖组合物
ES2399059T3 (es) * 2005-05-23 2013-03-25 Kraft Foods Global Brands Llc Composiciones potenciadoras del dulzor
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
CA2628265A1 (en) * 2005-11-08 2007-05-18 Multi Formulations Ltd. The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance
DE602006008985D1 (de) * 2005-12-16 2009-10-15 Nutricia Nv Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund
EP1977249A2 (en) * 2006-01-19 2008-10-08 Entress AB Method of diagnosis and method of treatment
CA2642761A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
MX2008012072A (es) * 2006-03-23 2008-11-25 Nestec Sa Suplemento nutricional alto en calorias.
MX2008012723A (es) * 2006-04-04 2008-10-14 Nestec Sa Tratamientos que usan citrulina.
CN101415414B (zh) * 2006-04-04 2013-06-12 雀巢产品技术援助有限公司 瓜氨酸在制备治疗矫正脓毒症患者中精氨酸缺乏的药物中的用途
PL379512A1 (pl) * 2006-04-21 2007-10-29 Sgp & Sons Ab Nowe metody i ich zastosowanie
CA2660291C (en) * 2006-08-09 2011-11-22 The Iams Company Methods of improving bone health and muscle health
FR2913885B1 (fr) * 2007-03-22 2012-07-20 Univ Paris Descartes Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines
EP2192898A1 (en) * 2007-09-11 2010-06-09 Northern Innovations And Formulations Corp. Composition and method for increasing the anabolic state of muscle cells
US20090156647A1 (en) * 2007-12-12 2009-06-18 Iovate T. & P. Inc. Method for maintaining physiological pH levels during intensive physical exercise
CA2610820A1 (en) * 2007-12-12 2008-12-29 Michele Molino Method for maintaining physiological ph levels during intensive physical exercise
WO2010002242A1 (en) * 2008-07-02 2010-01-07 N.V. Nutricia Nutritional composition for improving muscle function and daily activity
JP2010105946A (ja) * 2008-10-29 2010-05-13 Nof Corp 筋タンパク質増強剤及びこれを含む医薬品または食品
US20120178672A1 (en) * 2009-03-18 2012-07-12 Wolfe Robert R Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
WO2010137944A1 (en) * 2009-05-27 2010-12-02 N.V. Nutricia Treatment of hypercalcaemia
EP3231435A1 (en) * 2009-07-20 2017-10-18 Nestec S.A. Methods of attenuating the loss of functional status
WO2011019641A2 (en) * 2009-08-13 2011-02-17 Nestec S.A. Nutritional compositions including exogenous nucleotides
JP2013504572A (ja) * 2009-09-14 2013-02-07 ネステク ソシエテ アノニム 外因性ビタミンk2を含む炎症調節用栄養組成物

Similar Documents

Publication Publication Date Title
JP2014519483A5 (enExample)
RU2013151087A (ru) Питательные композиции, содержащие альфа-гикк и альфа - кетоглутарат
JP2014508156A5 (enExample)
EP2911530B1 (en) Encapsulated bitter peptides, methods of encapsulating bitter peptides, and nutritional compositions including encapsulated bitter peptides
AU2014290766B2 (en) Methods for promoting neuronal development and/or health
AU2008325032A1 (en) Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas
TW201501654A (zh) 包含具有刺激脂聯素性質之肽組份之營養組成物及其用途
RU2015133023A (ru) Активация адипонектина с использованием гидролизата казеина